Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 68071-2389, ATORVASTATIN CALCIUM, tablet, film coated, from NuCare Pharmaceuticals,Inc..

Product NDC
68071-2389
Status
Listed
Labeler
NuCare Pharmaceuticals,Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207687
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68071-2389 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM TRIHYDRATE10 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
68071-2389-36807123890330 TABLET, FILM COATED in 1 BOTTLE (68071-2389-3)
68071-2389-66807123890660 TABLET, FILM COATED in 1 BOTTLE (68071-2389-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c095d497-0634-6413-e053-2a95a90aa67f

Use it

Look up 68071-2389 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68071-2389 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68071-2389. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.